PPP1R13B and breast carcinoma: For instance, reduced expression of ASPP1 has been associated with worse outcomes in cancers such as acute lymphoblastic leukemia, breast cancer, hepatocellular carcinoma, clear-cell renal cell carcinoma, and colorectal cancer (10, 11, 15–17).